Testing effectiveness (Phase 2)Study completedNCT00976820
What this trial is testing
Safety and Immunogenicity of H1N1 Vaccines in Children Aged 6 Months to Less Than 9 Years of Age
Who this might be right for
Influenza
GlaxoSmithKline 323
Showing 20 of 0 results